drugset / Trial / NCT00223197

Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance Abuse

NCT00223197

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this research is to determine if pregnenolone supplement is associated with a reduction in substance use and craving in patients with recurrent major depressive disorder or bipolar disorder and substance abuse/dependence. This research also wants to explore if pregnenolone supplements are associated with improvement in psychiatric symptoms and memory, which are often negatively affected in these patients. It is hypothesized that patients receiving pregnenolone supplements would show greater improvements in mood symptoms and memory, and crave substances less than the patients receiving placebo.

Timeline

Start
2004-02
Primary completion
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregnenolone Other / unclassified 50 mg Oral
Subject Pregnenolone Other / unclassified 100 mg Oral